Patrick Till

Patrick Till is a seasoned professional in the life sciences sector, currently serving as Managing Partner at Meru Advisors since October 2022 and as an Advisor for the SPARK Translational Research Program at Stanford University since November 2023. Prior to these roles, Patrick held the position of Senior Director at Celldex Therapeutics from April 2021 to October 2022 and served as Vice President of Life Sciences at Solebury Trout from May 2014 to April 2021. Earlier experience includes an Analyst role in Life Sciences at Warwick Ventures from September 2012 to September 2013. Patrick earned a Bachelor of Science (BSc) in Biology/Biological Sciences from the University of Warwick between 2010 and 2013.